Search for: "United States et al v. Universal Health Services, Inc., et al."
Results 101 - 120
of 127
Sort by Relevance
|
Sort by Date
12 Apr 2010, 10:44 am
Click Here American Trucking Association et al. v. [read post]
16 Feb 2010, 2:17 am
An example of this is Loma Linda University Adventist Health Sciences Center, et al. v. [read post]
25 Jan 2010, 3:51 am
(IP finance) The UK IP Office issues a Virgin trademark ruling that contrasts the Israel approach (IP Factor) EWHC (Pat): Article 27 (to prevent parallel proceedings in different member states) requires flexible approach to meaning of ‘same parties’: Mölnlycke Health Care AB (MAB), Mölnlycke Health care Limited (MUK) v. [read post]
16 Oct 2009, 3:18 pm
The Commission on Dietary Supplement Labels (the Commission), a seven-member body that was established under DSHEA to "provide recommendations for...the regulation of label claims and statements for dietary supplements, including the use of literature in connection with the sale of dietary supplements and procedures for the evaluation of such claims," held public meetings around the United States from 1996 through 1997. [read post]
22 Sep 2009, 11:00 am
United Federation of Teachers et al., amici curiae. [read post]
21 Sep 2009, 5:35 am
The New York Times’ Adam Liptak covers United States v. [read post]
27 Jul 2009, 7:18 am
Wal-Mart Stores Inc, et al (Peter Zura's 271 Patent Blog) District Court N D Illinois: Inventor/plaintiff’s Managing Director not given highly confidential technical information: McDavid Knee Guard Inc v Nike USA Inc (Chicago Intellectual Property Law Blog) District Court E D Pennsylvania: Warsaw Orthpedic awarded $2M in Globus patent dispute (Patent Docs) District Court E D Texas: ‘I have good cause but it’s a… [read post]
5 Jul 2009, 5:01 pm
Tinker et al. v. [read post]
12 May 2009, 12:52 pm
The Respondent contracts with the United States Marshals Service (USMS) to provide security services at federal courthouses. [read post]
26 Jan 2009, 3:51 am
R.R., Inc., No. 07-2512 (6th Cir. [read post]
22 Dec 2008, 12:07 pm
Sixth Circuit Holds Disabled Retirees Lack Standing to Bring Claims Under Disabilities ActLeroy McKnight, et al. v. [read post]
1 Sep 2008, 9:46 am
Aug 29, 2008)(Corrected Opinion by Brister) IN RE MCALLEN MEDICAL CENTER, INC., D/B/A MCALLEN MEDICAL CENTER AND UNIVERSAL HEALTH SERVICES, INC.; from Hidalgo County; 13th district(13-05-00441-CV, ___ SW3d ___, 10-05-05)real parties in interest's motion for oral argument deniedcorrected opinion issued Forest Oil Corp v. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
27 Jun 2008, 10:04 am
Porsche AG: (Class 46), WIPO: Yell Limited v Yell.travel: domain name yell.travel to be transferred to Yell Limited: (Class 46), Some see rise in non-traditional trade marks; national registries not yet: (Intellectual Property Watch) Global - Patents Lower patentability standards – strategic responses: (IP Thinktank), IP Business Congress sees Finnish inventor become a millionaire: (IAM), Ron Slusky: Five prescriptions for effectively analysing an invention and then… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore… [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), Domain name transfer made easier: (Australian Trade Marks Law Blog), Quantum of obviousness in Australian patent laws - C Lawson: (IP Down Under), Separating Sony sheep from Grokster (and Kazaa) goats: Reckoning [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
